Agomelatine (L(+)-Tartaric acid)

CAS: 824393-18-2 货号: A656219 分子式: C19H23NO8 分子量: 393.39 PubChem CID: 78357824
有货
级别和纯度: 10mM in DMSO
别名
阿戈美拉汀(L(+)-酒石酸)
储存条件
干燥,-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
A656219-1ml
期货 Stock Image
¥506.90
请输入您要添加的产品数量

概述


Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with K i s of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pK i s of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively .

In Vitro

Agomelatine (S 20098) acts as a full agonist of MT1 and MT2 receptors with EC 50 s of 1.6±0.4, 0.10±0.04 nM for CHO hMT1 CHO-hMT2 (hΜΤ1 and hΜΤ2 receptors expressed in CHO or HEK cell membranes). Agomelatine (S20098) also interacts with h5-HT2B receptors (6.6), whereas it shows low affinity at native (rat)/cloned, human 5-HT2A (<5.0/5.3) and 5-HT1A (<5.0/5.2) receptors, and negligible (<5.0) affinity for other 5-HT receptors. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Agomelatine (25, 50, or 75 mg/kg; i.p.) has antioxidant activity in Strychnine (75 mg/kg, i.p.) or Pilocarpine (400 mg/kg, i.p.) induced seizure models in mice. Agomelatine dose not have any antioxidant effects on parameters of oxidative stress produced by Pentylenetetrazole (PTZ) or Picrotoxin (PTX) induced seizure models when compared to controls. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Female Swiss mice (20-30 g) were administered PTZ (85 mg/kg, i.p.), PTX (7 mg/kg, i.p.), strychnine (75 mg/kg, i.p.), Pilocarpine (400 mg/kg, i.p.), respectivelyDosage: 25, 50, or 75 mg/kg Administration: Administered intraperitoneally (i.p.) Result: All dosages showed a significant decrease in thiobarbituric acid reactive substances (TBARS) levels and nitrite content in all brain areas when compared to controls in the Pilocarpine induced seizure model. All dosages decreased TBARS levels in all brain areas, and at low doses (25 or 50 mg/kg) decreased nitrite contents, but only at 25 or 50 mg/kg showed a significant increase in catalase activity in three brain areas when compared to controls in the Strychnine-induced seizure model. Did not have any antioxidant effects on parameters of oxidative stress produced by PTX- or PTZ-induced seizure models when compared to controls.

IC50& Target:5-HT 2C Receptor 6.4 (pKi, native porcine) 5-HT 2C Receptor 6.2 (pKi, human) hMT1 0.1 nM (Ki, CHO Cells) hMT1 0.06 nM (Ki, HEK Cells) hMT2 0.12 nM (Ki, CHO Cells) hMT2 0.27 nM (Ki, HEK Cells)

规格

别名
阿戈美拉汀(L(+)-酒石酸)
规格或纯度
10mM in DMSO
英文名称
Agomelatine (L(+)-Tartaric acid)
生化机理
阿戈美拉汀 L(+)- 酒石酸(S-20098 L(+)- 酒石酸)是 MT1 和 MT2 受体的特异性激动剂,对 CHO-hMT1、HEK-hMT1、CHO-hMT2 和 HEK-hMT2 的 K i s 分别为 0.1、0.06、0.12 和 0.27 nM。阿戈美拉汀-L(+)-酒石酸是一种具有
储存条件
干燥,-80℃储存
运输条件
特低温运输
作用类型
拮抗剂
名称和识别符
分子类型
小分子
Isomeric SMILES
CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
PubChem CID
分子量
393.39

高级数据

质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器